192 related articles for article (PubMed ID: 7525911)
1. Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis.
Jones JL; Berth-Jones J; Fletcher A; Hutchinson PE
J Pathol; 1994 Oct; 174(2):77-82. PubMed ID: 7525911
[TBL] [Abstract][Full Text] [Related]
2. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
3. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
4. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
[TBL] [Abstract][Full Text] [Related]
6. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis.
Alshenawy HA; Hasby EA
Cell Immunol; 2011; 269(2):115-9. PubMed ID: 21470599
[TBL] [Abstract][Full Text] [Related]
8. Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions.
Bieber T; Braun-Falco O
Acta Derm Venereol; 1989; 69(2):175-8. PubMed ID: 2564240
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
10. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
11. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
Erkin G; Uğur Y; Gürer CK; Aşan E; Korkusuz P; Sahin S; Kölemen F
J Cutan Pathol; 2007 Mar; 34(3):213-9. PubMed ID: 17302604
[TBL] [Abstract][Full Text] [Related]
12. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
[TBL] [Abstract][Full Text] [Related]
13. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
Horrocks C; Holder JE; Berth-Jones J; Camp RD
Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of cellular events in lesional skin during common virus infections.
Tsukahara T; Horiuchi Y
J Dermatol; 1996 Jan; 23(1):22-32. PubMed ID: 8720254
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the Koebner reaction and T lymphocytes in uninvolved psoriatic skin.
Baker BS; Powles AV; Lambert S; Valdimarsson H; Fry L
Acta Derm Venereol; 1988; 68(5):430-4. PubMed ID: 2461028
[TBL] [Abstract][Full Text] [Related]
16. Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.
Roosje PJ; Whitaker-Menezes D; Goldschmidt MH; Moore PF; Willemse T; Murphy GF
Am J Pathol; 1997 Oct; 151(4):927-32. PubMed ID: 9327725
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
18. Cellular interactions and adhesion molecules in psoriatic skin.
de Boer OJ; Verhagen CE; Visser A; Bos JD; Das PK
Acta Derm Venereol Suppl (Stockh); 1994; 186():15-8. PubMed ID: 7915480
[TBL] [Abstract][Full Text] [Related]
19. In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.
Pasch MC; Timár KK; van Meurs M; Heydendael VM; Bos JD; Laman JD; Asghar SS
J Pathol; 2004 Jul; 203(3):839-48. PubMed ID: 15221944
[TBL] [Abstract][Full Text] [Related]
20. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]